QBFM
EPZM

QS Batterymarch Financial Management’s Epizyme, Inc EPZM Stock Holding History

QS Batterymarch Financial Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2.78M Sell
102,466
-9,400
-8% -$292K 0.07% 359
2014
Q2 		$3.48M Sell
111,866
-9,100
-8% -$214K 0.09% 352
2014
Q1 		$2.75M Sell
120,966
-4,400
-4% -$133K 0.06% 431
2013
Q4 		$2.61M Sell
125,366
-1,000
-0.8% -$29K 0.06% 430
2013
Q3 		$5.05M Buy
+126,366
New +$4.28M 0.11% 295

Other funds holding EPZM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

QS Batterymarch Financial Management's EPZM Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Epizyme, Inc (EPZM) stake by 8.4% in Q3 2014, selling an estimated $292K and leaving 102,466 shares worth $2.78M. The position accounts for 0.07% of the portfolio, ranked #359.

QS Batterymarch Financial Management first reported a position in EPZM in Q3 2013 and has held it in 5 quarters since. The position peaked at $5.05M in Q3 2013. 94 funds tracked by Wall St. Rank hold EPZM as of Q3 2014.

  • QS Batterymarch Financial Management held 102,466 shares of Epizyme, Inc worth $2.78M as of Q3 2014.
  • QS Batterymarch Financial Management sold 9,400 Epizyme, Inc shares in Q3 2014, an estimated $292K.
  • Epizyme, Inc made up 0.07% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #359 holding.
  • QS Batterymarch Financial Management first reported a position in Epizyme, Inc in Q3 2013 and has held it in 5 quarters since.
  • QS Batterymarch Financial Management's Epizyme, Inc position peaked at $5.05M in Q3 2013.
  • 94 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.